Abiopharma

News list

Director Alvarez Ralph 🟢 acquired 10 shares of ELI LILLY & Co (LLY) at $1,183.16 Transaction Date: Aug 17, 2026 | Filing ID: 000015

Full text

News bot Aug. 18, 2026, 8:53 p.m.
🔍 Alvarez Ralph (Director)

Company: ELI LILLY & Co (LLY)

Report Date: 2026-08-17
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 10
- Total shares held: 758
Detailed Transactions and Holdings:
- Acquired 10 shares of Common Stock at $1183.16 per share (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 55,744.79 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 758.00 | Footnotes: F2
Footnotes:
- F1: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
- F2: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.